{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"diazoxide-resistant-focal-hyperinsulinism-due-to-sur1-deficiency","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A rare, congenital, isolated hyperinsulinism disorder characterised by diazoxide unresponsive recurrent episodes of hyperinsulinaemic hypoglycaemia resulting from an excessive insulin secretion by the pancreatic beta-cells due to a mutation in the ABCC8 gene. Pancreatic involvement is focal and can be cured by a selective partial pancreatectomy. Hypoglycaemia may lead to variable clinical manifestations, ranging from asymptomatic hypoglycaemia revealed by routine blood glucose monitoring to macrosomia at birth, mild to moderate hepatomegaly and life-threatening hypoglycaemic coma or status epilepticus, further leading to poor neurological outcome.","mondoId":"MONDO:0017187","node":{"canonicalSlug":"diazoxide-resistant-focal-hyperinsulinism-due-to-sur1-deficiency","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency","originalSourceId":"ORPHA:276598","paragraphs":["A rare, congenital, isolated hyperinsulinism disorder characterised by diazoxide unresponsive recurrent episodes of hyperinsulinaemic hypoglycaemia resulting from an excessive insulin secretion by the pancreatic beta-cells due to a mutation in the ABCC8 gene. Pancreatic involvement is focal and can be cured by a selective partial pancreatectomy. Hypoglycaemia may lead to variable clinical manifestations, ranging from asymptomatic hypoglycaemia revealed by routine blood glucose monitoring to macrosomia at birth, mild to moderate hepatomegaly and life-threatening hypoglycaemic coma or status epilepticus, further leading to poor neurological outcome."],"rawAttribution":"ORPHA:276598","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:20Z","upstream":"ORPHA:276598","url":"https://rarediseases.info.nih.gov/diseases/17285"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"hyperinsulinemic hypoglycemia, familial, 1","mondoId":"MONDO:0009734","slug":"hyperinsulinemic-hypoglycemia-familial-1"},{"kind":"parent","label":"diazoxide-resistant focal hyperinsulinism","mondoId":"MONDO:0019265","slug":"diazoxide-resistant-focal-hyperinsulinism"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17285\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:276598</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, congenital, isolated hyperinsulinism disorder characterised by diazoxide unresponsive recurrent episodes of hyperinsulinaemic hypoglycaemia resulting from an excessive insulin secretion by the pancreatic beta-cells due to a mutation in the ABCC8 gene. Pancreatic involvement is focal and can be cured by a selective partial pancreatectomy. Hypoglycaemia may lead to variable clinical manifestations, ranging from asymptomatic hypoglycaemia revealed by routine blood glucose monitoring to macrosomia at birth, mild to moderate hepatomegaly and life-threatening hypoglycaemic coma or status epilepticus, further leading to poor neurological outcome.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17285\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"diazoxide-resistant-focal-hyperinsulinism-due-to-sur1-deficiency","sourceDocuments":[{"name":"GARD: Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency","reviewed":null,"source_release":"2026-10-25T03:42:20Z","url":"https://rarediseases.info.nih.gov/diseases/17285"}],"sourceNote":"","synonyms":["hyperinsulinemic hypoglycemia due to SUR1 deficiency, diazoxide-resistant focal form"],"takeawayHtml":"","title":"diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency"},"schemaVersion":1}
